Participation of brainstem monoaminergic nuclei in behavioral depression

Pharmacology Biochemistry and Behavior

Volumn 100, Issue 2, 2011, Pages 330-339

  Lin, Yan ^a   Sarfraz, Yasmeen ^a   Jensen, Ashley ^b   Dunn, Adrian J ^b   Stone, Eric A ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

DBH SAP immunotoxin; Depression; DSP4; Lesion; Motor activity; Noradrenergic system

Indexed keywords

2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; DOPAMINE BETA HYDROXYLASE SAPORIN IMMUNOTOXIN; ENDOTOXIN; NEUROTOXIN; REBOXETINE; UNCLASSIFIED DRUG;

ANHEDONIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN STEM; CELL COUNT; CONTROLLED STUDY; DEPRESSION; DORSAL RAPHE NUCLEUS; EXPERIMENTAL TEST; FORCED SWIMMING TEST; LOCOMOTION; LOCUS CERULEUS; MALE; MONOAMINE NERVE CELL; MOUSE; NERVE CELL LESION; NONHUMAN; NORADRENERGIC NERVE; PRIORITY JOURNAL; TAIL SUSPENSION TEST; VENTRAL TEGMENTUM;

ANIMALS; BIOGENIC MONOAMINES; BRAIN STEM; CELL NUCLEUS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEPRESSION; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; MICE;

MUS;

EID: 80054812323     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.08.021     Document Type: Article

References (117)

1. R. Abolfazli, M. Hosseini, A. Ghanizadeh, A. Ghaleiha, M. Tabrizi, and M. Raznahan Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression Depress Anxiety 28 2011 297 302
2. H. Akaoka, B. Roussel, J.-S. Lin, G. Chouvet, and M. Jouvet Effect of modafinil and amphetamine on the rat catecholaminergic neuron activity Neurosci Lett 123 1991 20 22
3. T. Archer, and A. Frediksson An antihypokinesic action α2-adrenoceptors upon MPTP-induced behaviour deficits in mice J Neural Transm 110 2003 183 200 (Pubitemid 36216500)
4. T. Archer, A. Fredriksson, G. Jonsson, T. Lewander, A. Mohammed, and S. Ross Central noradrenaline depletion antagonizes aspects of d-amphetamine- induced hyperactivity in the rat Psychopharmacology 88 1986 141 146 (Pubitemid 16165671)
5. A. Armario Activation of the hypothalamic-pituitary-adrenal axis by addictive drugs: different pathways, common outcome Trends Pharmacol Sci 31 2010 318 325
6. D.A. Barton, M.D. Esler, T. Dawood, E.A. Lambert, D. Haikerwal, and C. Brenchley Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy Arch Gen Psychiatry 65 2008 38 46
7. G. Bissette, V. Klimek, J. Pan, C. Stockmeier, and G. Ordway Elevated concentrations of CRF in the locus coeruleus of depressed subjects Neuropsychopharmacology 28 2003 1328 1335 (Pubitemid 41070903)
8. D.R. Britton, C. Ksir, K.T. Britton, D. Young, and G.F. Koob Brain norepinephrine depleting lesions selectively enhance behavioral responsiveness to novelty Physiol Behav 33 1984 473 478 (Pubitemid 14010077)
9. K. Buller, Y. Xu, C. Dayas, and T. Day Dorsal and ventral medullary catecholamine cell groups contribute differentially to systemic interleukin-1beta-induced hypothalamic pituitary adrenal axis responses Neuroendocrinology 73 2001 129 138 (Pubitemid 32217873)
10. M.E. Carter, O. Yizhar, S. Chikahisa, H. Nguyen, A. Adamantidis, and S. Nishino Tuning arousal with optogenetic modulation of locus coeruleus neurons Nat Neurosci 13 2010 1526 1533
11. T. Cassano, S. Gaetani, M.G. Morgese, T. Macheda, L. Laconca, and P. Dipasquale Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion Neurochem Res 34 2009 1417 1426
12. V. Cuomo, R. Cagiano, N. Brunello, R. Fumagalli, and G. Racagni Behavioural changes after acute and chronic administration of typical and atypical antidepressants in rats: interactions with reserpine Neurosci Lett 40 1983 315 319 (Pubitemid 13016712)
13. C.V. Dayas, K.M. Buller, J.W. Crane, Y. Xu, and T.A. Day Stressor categorization: acute physical and psychological stressors elicit distinctive recruitment patterns in the amygdala and in medullary noradrenergic cell groups Eur J Neurosci 14 2001 1143 1152 (Pubitemid 35463758)
14. N. DellaGioia, and J. Hannestad A critical review of human endotoxin administration as an experimental paradigm of depression Neurosci Biobehav Rev 34 2010 130 143
15. K. Demyttenaere, J. De Fruyt, and S.M. Stahl The many faces of fatigue in major depressive disorder Int J Neuropsychopharmacol 8 2005 93 105 (Pubitemid 40388818)
16. A.J. Dunn Stress-related changes in cerebral catecholamine and indoleamine metabolism: lack of effect of adrenalectomy and corticosterone J Neurochem 51 1988 406 412
17. D.M. Eagle, O. Lehmann, D.E. Theobald, Y. Pena, R. Zakaria, and R. Ghosh Serotonin depletion impairs waiting but not stop-signal reaction time in rats: implications for theories of the role of 5-HT in behavioral inhibition Neuropsychopharmacology 34 2009 1311 1321
18. G.D. Ellison Behavior and the balance between norepinephrine and serotonin Acta Neurobiol Exp 35 1975 499 515
19. E. Esposito, G. Ossowska, and R. Samanin Further evidence that noradrenaline is not involved in the anti-immobility activity of chronic desipramine in the rat Eur J Pharmacol 136 1987 429 432 (Pubitemid 17109628)
20. F. Frenois, M. Moreau, J. OConnor, M. Lawson, C. Micon, and J. Lestage Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior Psychoneuroendocrinology 32 2007 516 531 (Pubitemid 46756007)
21. J.A. Garcia-Sevilla, P.V. Escriba, A. Ozaita, R. La Harpe, C. Walzer, and A. Eytan Up-regulation of immunolabeled alpha2A-adrenoceptors, Gi coupling proteins, and regulatory receptor kinases in the prefrontal cortex of depressed suicides J Neurochem 72 1999 282 291 (Pubitemid 29013903)
22. R.P.A. Gaykema, and L.E. Goehler Lipopolysaccharide challenge-induced suppression of Fos in hypothalamic orexin neurons: their potential role in sickness behavior Brain Behav Immun 23 2009 926 930
23. R.P.A. Gaykema, and L.E. Goehler Ascending caudal medullary catecholamine pathways drive sickness-induced deficits in exploratory behavior: brain substrates for fatigue? Brain Behav Immun 25 2011 443 460
24. M. Gesi, P. Soldani, F.S. Giorgi, A. Santinami, I. Bonaccorsi, and F. Fornai The role of the locus coeruleus in the development of Parkinson's disease Neurosci Biobehav Rev 24 2000 655 668 (Pubitemid 30625131)
25. M.J. Glass, E.E. Colago, and V.M. Pickel Alpha-2A-adrenergic receptors are present on neurons in the central nucleus of the amygdala that project to the dorsal vagal complex in the rat Synapse 46 2002 258 268 (Pubitemid 35239748)
26. A.W. Goddard, S.G. Ball, J. Martinez, M.J. Robinson, C.R. Yang, and J.M. Russell Current perspectives of the roles of the central norepinephrine system in anxiety and depression Depress Anxiety 27 2010 339 350
27. P. Gold, and G. Chrousos Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states Mol Psychiatry 7 2002 254 262
28. M.M. Gonzalez, and G. Aston-Jones Light deprivation damages monoamine neurons and produces a depressive behavioral phenotype in rats Proc Natl Acad Sci U S A 105 2008 4898 4903 (Pubitemid 351753843)
29. R.E. Grahn, S.E. Hammack, M.J. Will, K.A. O'Connor, T. Deak, and P.D. Sparks Blockade of alpha1 adrenoreceptors in the dorsal raphe nucleus prevents enhanced conditioned fear and impaired escape performance following uncontrollable stressor exposure in rats Behav Brain Res 134 2002 387 392 (Pubitemid 34912717)
30. K. Gyires, Z.S. Zadori, T. Torok, and P. Matyus Alpha-2-adrenoceptor subtypes-mediated physiological, pharmacological actions Neurochem Int 55 2009 447 453
31. R. Haidkind, M. Eller, M. Harro, A. Kask, A. Rinken, and L. Oreland Effects of partial locus coeruleus denervation and chronic mild stress on behaviour and monoamine neurochemistry in the rat Eur Neuropsychopharmacol 13 2003 19 28 (Pubitemid 35449733)
32. A.S. Hare, G. Clarke, and S. Tolchard Bacterial lipopolysacharide-induced changes in fos protein expression in the rat brain: correlation with thermoregulatory changes and plasma corticosterone J Neuroendocrinol 7 1995 791 799
33. J. Harro, R. Pähkla, A.R. Modiri, M. Harro, A. Kask, and L. Oreland Dose-dependent effects of noradrenergic denervation by DSP-4 treatment on forced swimming and β-adrenoceptor binding in the rat J Neural Transm 106 1999 619 629 (Pubitemid 29401351)
34. 4 potentiates the behavioral effects of MK-801 in rats Pharmacol Biochem Behav 62 1999 233 237 (Pubitemid 29070886)
35. D.J. Heal Phenylephrine-induced activity in mice as a model of central a1-adrenoceptor function. Effects of acute and repeated administration of antidepressant drugs and electroconvulsive shock Neuropharmacology 23 1984 1241 1251 (Pubitemid 15193832)
36. S.C. Heinrichs, and G.F. Koob Corticotropin-releasing factor in brain: a role in activation, arousal, and affect regulation J Pharmacol Exp Ther 311 2004 427 440 (Pubitemid 39391526)
37. Z.S. Herman, R. Brus, A. Drybanski, R. Szkilnik, and J. Slominska-Zurek Influence of 6-hydroxydopamine on the behavioral effects induced by apomorphine or clonidine in rats Psychopharmacology 50 1976 73 80
38. I. Herrera-Guzman, E. Gudayol-Ferre, D. Herrera-Guzman, J. Guardia-Olmos, E. Hinojosa-Calvo, and J.E. Herrera-Abarca Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder J Psychiatr Res 43 2009 855 863
39. J.P. Heybach, G.D. Coover, and C.E. Lints Behavioral effects of neurotoxic lesions of the ascending monoamine pathways in the rat brain J Comp Physiol Psychol 92 1978 58 70 (Pubitemid 8274387)
40. R.N. Hughes, and J.M. Pither Chronic imipramine effects on exploratory behavior in rats Pharmacol Biochem Behav 27 1987 359 362 (Pubitemid 17106871)
41. K. Itoi, and N. Sugimoto The brainstem noradrenergic systems in stress, anxiety, and depression J Neuroendocrinol 22 2010 355 361
42. K. Itoi, N. Sugimoto, S. Suzuki, K. Sawada, G. Das, and K. Uchida Targeting of locus ceruleus noradrenergic neurons expressing human interleukin-2 receptor alpha-subunit in transgenic mice by a recombinant immunotoxin anti-Tac(Fv)-PE38: a study for exploring noradrenergic influence upon anxiety-like and depression-like behaviors J Neurosci 31 2011 6132 6139
43. G. Jonsson, H. Hallman, A. Ponzoni, and S. Ross DSP4 (N-(2-dhloroethyl)- N-ethyl-2-bromobenzylamine) - a useful denervation tool for central and peripheral noradrenaline neurons Eur J Pharmacol 72 1981 173 186
44. B. Karolewicz, L. Johnson, K. Szebeni, C.A. Stockmeier, and G.A. Ordway Glutamate signaling proteins and tyrosine hydroxylase in the locus coeruleus of alcoholics J Psychiatr Res 42 2008 348 355 (Pubitemid 351253579)
45. Y. Kitada, T. Miyauchi, A. Satoh, and S. Satoh Effects of antidepressants in the rat forced swimming test Eur J Pharmacol 72 1981 145 152 (Pubitemid 11072492)
46. I.T. Kitayama, M. Otani, and S. Murase Degeneration of the locus ceruleus noradrenergic neurons in the stress-induced depression of rats Ann N Y Acad Sci 1148 2008 95 98
47. C. Kohlhauser, S. Kaehler, W. Mosgoeller, N. Singewald, D. Kouvelas, and H. Prast Histological changes and neurotransmitter levels three months following perinatal asphyxia in the rat Life Sci 64 1999 2109 2124 (Pubitemid 29236571)
48. Y. Lin, R.F. Suckow, Y. Sarfraz, and E.A. Stone Further evidence for an immediate antidepressant action of intracerebral drug administration in a model of chronic depression Int J Neuropsychopharmacol 14 2011 691 696
49. C. López-Rubalcava, and I. Lucki Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test Neuropsychopharmacology 22 2000 191 199 (Pubitemid 30016020)
50. M.M. Marcus, C. Wiker, O. Franberg, A. Konradsson-Geuken, X. Langlois, and K. Jardemark Adjunctive alpha2-adrenoceptor blockade enhances the antipsychotic-like effect of risperidone and facilitates cortical dopaminergic and glutamatergic, NMDA receptor-mediated transmission Int J Neuropsychopharmacol 13 2010 891 903
51. M. Marien, M. Briley, and F. Colpaert Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice Eur J Pharmacol 236 1993 487 489 (Pubitemid 23170392)
52. F.A. Marvel, C.C. Chen, N. Badr, R.P. Gaykema, and L.E. Goehler Reversible inactivation of the dorsal vagal complex blocks lipopolysaccharide- induced social withdrawal and c-Fos expression in central autonomic nuclei Brain Behav Immun 18 2004 123 134 (Pubitemid 38169157)
53. S.T. Mason, D.C. Roberts, and H.C. Fibiger Noradrenergic influences on catalepsy Psychopharmacology 60 1978 53 57 (Pubitemid 9089698)
54. S.T. Mason, M.E. Corcoran, and H.C. Fibiger Noradrenergic processes involved in the locomotor effects of ethanol Eur J Pharmacol 54 1979 383 387 (Pubitemid 9200980)
55. S. Maswood, J.E. Barter, L.R. Watkins, and S.F. Maier Exposure to inescapable but not escapable shock increases extracellular levels of 5-HT in the dorsal raphe nucleus of the rat Brain Res 783 1998 115 120 (Pubitemid 28131428)
56. S. Matsuda, H. Peng, H. Yoshimura, T.C. Wen, T. Fukuda, and M. Sakanaka Persistent c-fos expression in the brains of mice with chronic social stress Neurosci Res 26 1996 157 170 (Pubitemid 26386997)
57. M. Mavridis, A.-D. Degryse, A.J. Lategan, M.R. Marien, and F.C. Colpaert Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of parkinson's disease Neuroscience 41 1991 507 523
58. A.C. Mercado, L.J. Carroll, J.D. Cassidy, and P. Côté Passive coping is a risk factor for disabling neck or low back pain Pain 117 2005 51 57 (Pubitemid 41764772)
59. W. Merrick The experience of psychopathology: investigating mental disorders in their natural settings Vries Md, Dysphoric moods in depressed and non-depressed adolescents 1992 Cambridge Univ Press Cambridge 148 156
60. J. Murrough, K. Boss-Williams, M. Emery, R. Bonsall, and J. Weiss Depletion of brain norepinephrine does not reduce spontaneous ambulatory activity of rats in the home cage Brain Res 883 2000 125 130
61. L. Musazzi, M. Milanese, P. Farisello, S. Zappettini, D. Tardito, and V.S. Barbiero Acute stress increases depolarization-evoked glutamate release in the rat prefrontal/frontal cortex: the dampening action of antidepressants PLoS One 5 2010 e8566
62. S. Nassif, E. Kempf, B. Cardo, and L. Velley Neurochemical lesion of the locus coeruleus of the rat does not suppress the sedative effect of clonidine Eur J Pharmacol 91 1983 69 76 (Pubitemid 13078983)
63. C. Nemeroff Recent advances in the neurobiology of depression Psychopharmacol Bull 36 Suppl. 2 2002 6 23
64. S.I. Neophytou, S. Aspley, S. Butler, S. Beckett, and C.A. Marsden Effects of lesioning noradrenergic neurones in the locus coeruleus on conditioned and unconditioned aversive behaviour in the rat Prog Neuropsychopharmacol Biol Psychiatry 25 2001 1307 1321 (Pubitemid 32835286)
65. R.J. Niesink, and J.M. Van Ree Antidepressant drugs normalize the increased social behaviour of pairs of male rats induced by short term isolation Neuropharmacology 21 1982 1343 1348 (Pubitemid 13196701)
66. H. Nishimura, A. Tsuda, M. Oguchi, Y. Ida, and M. Tanaka Is immobility of rats in the forced swim test "behavioral despair?" Physiol Behav 42 1988 93 95 (Pubitemid 18050895)
67. S.O. Ogren, T. Archer, and C. Johansson Evidence for a selective brain noradrenergic involvement in the locomotor stimulant effects of amphetamine in the rat Neurosci Lett 43 1983 327 331 (Pubitemid 14154792)
68. S. Owen, M.R. Boarder, J.A. Gray, and M. Fillenz Acquisition and extinction of continuously and partially reinforced running in rats with lesions of the dorsal noradrenergic bundle Behav Brain Res 5 1982 11 41 (Pubitemid 12100513)
69. F. Petty, J.L. Sacquitne, and A.D. Sherman Tricyclic antidepressant drug action correlates with its tissue levels in anterior neocortex Neuropharmacology 21 1982 475 477 (Pubitemid 12112507)
70. M.J. Picklo, R.G. Wiley, D.A. Lappi, and D. Robertson Noradrenergic lesioning with an anti-dopamine beta-hydroxylase immunotoxin Brain Res 666 1994 195 200 (Pubitemid 24369031)
71. A. Plaznik, E. Tamborska, M. Hauptmann, A. Bidzinski, and W. Kostowski Brain neurotransmitter systems mediating behavioral deficits produced by inescapable shock treatment in rats Brain Res 447 1988 122 132
72. A. Plaznik, W. Palejko, R. Stefanski, and W. Kostowski Open field behavior of rats reared in different social conditions: the effects of stress and imipramine Pol J Pharmacol 45 1993 243 252 (Pubitemid 23276697)
73. M.I.A. Porceddu, M. Melis, and G. DiChiara Role of ventral mesencephalic reticular formation and related noradrenergic and serotonergic bundles in turning behavior as investigated by means of kainate, 6-hydroxydopamine and 5,7-dihydroxytryptamine lesions Brain Res 262 1983 187 200 (Pubitemid 13148306)
74. R.D. Porsolt, G. Anton, N. Blavet, and M. Jalfre Behavioral despair in rats: a new model sensitive to antidepressant treatments Eur J Pharmacol 47 1978 379 381
75. C.E. Renard, E. Dailly, D.J. David, M. Hascoet, and M. Bourin Monoamine metabolism changes following the mouse forced swimming test but not the tail suspension test Fundam Clin Pharmacol 17 2003 449 455 (Pubitemid 36920646)
76. N. Ripoll, D.J.P. David, E. Dailly, M. Hascoët, and M. Bourin Antidepressant-like effects in various mice strains in the tail suspension test Behav Brain Res 143 2003 193 200 (Pubitemid 36937164)
77. D.C. Roberts, A.P. Zis, and H.C. Fibiger Ascending catecholamine pathways and amphetamine-induced locomotor activity: importance of dopamine and apparent non-involvement of norepinephrine Brain Res 93 1975 441 454
78. B.J. Sahakian, P. Winn, T.W. Robbins, R.J. Deeley, B.J. Everitt, and L.T. Dunn Changes in body weight and food-related behaviour induced by destruction of the ventral or dorsal noradrenergic bundle in the rat Neuroscience 10 1983 1405 1420 (Pubitemid 14178583)
79. G. Sanacora, R.M. Berman, A. Cappiello, D.A. Oren, A. Kugaya, and N. Liu Addition of the alpha2-antagonist yohimbine to fluoxetine: effects on rate of antidepressant response Neuropsychopharmacology 29 2004 1166 1171 (Pubitemid 38670053)
80. J. Sawynok, A. Reid, and G. Doak Caffeine antinociception in the rat hot-plate and formalin tests and locomotor stimulation: involvement of noradrenergic mechanisms Pain 61 1995 203 213
81. 2A- adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety J Neurosci 21 2001 4875 4882 (Pubitemid 32565645)
82. D. Schrijvers, Y.J. Maas, M.P. Pier, Y. Madani, W. Hulstijn, and B.G. Sabbe Psychomotor changes in major depressive disorder during sertraline treatment Neuropsychobiology 59 2009 34 42
83. D. Schulz, T. Buddenberg, and J.P. Huston Extinction-induced "despair" in the water maze, exploratory behavior and fear: effects of chronic antidepressant treatment Neurobiol Learn Mem 87 2007 624 634 (Pubitemid 46483124)
84. R.K. Schwarting, and R. Carey Differential behavioural effects after subtotal depletions of dopamine or noradrenaline in the ventral striatum Funct Neurol 3 1988 29 36
85. J. Semba, and R. Takahashi Effect of monoamine precursors on the forced-swimming test in mice Psychopharmacology 95 1988 222 225
86. P.E. Simson, and J. Weiss Altered activity of the locus coeruleus in an animal model of depression Neuropsychopharmacology 1 1988 287 295 (Pubitemid 19126148)
87. P.G. Simson, J. Weiss, L.J. Hoffman, and M.J. Ambrose Reversal of behavioral depression by infusion of an alpha-2 adrenergic agonist into the locus coeruleus Neuropharmacology 25 1986 385 389 (Pubitemid 16109574)
88. C. Spyraki, and H.C. Fibiger Clonidine-induced sedation in rats: evidence for mediation by postsynaptic alpha 2-adrenoreceptors J Neural Transm 54 1982 153 163 (Pubitemid 12022950)
89. J. Srinivasan, and W.J. Schmidt Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease Behav Brain Res 151 2004 191 199 (Pubitemid 38501442)
90. L. Steru, R. Chermat, B. Thierry, and P. Simon The tail suspension test: a new method for screening antidepressants in mice Psychopharmacology 85 1985 367 370 (Pubitemid 15123115)
91. E.A. Stone, and D. Quartermain Alpha 1-noradrenergic neurotransmission, corticosterone and behavioral depression Biol Psychiatry 46 1999 1287 1300
92. 1-adrenergic neurotransmission is necessary for behavioral activation to environmental change in mice Neuroscience 94 1999 1245 1252 (Pubitemid 29509689)
93. 1B-adrenoceptors in modafinil-induced behavioral activity Synapse 46 2002 269 270 (Pubitemid 35239749)
94. E.A. Stone, G. Grunewald, Y. Lin, R. Ahsan, H. Rosengarten, and K. Kramer Role of epinephrine stimulation of CNS α1-adrenoceptors in motor activity in mice Synapse 49 2003 67 76 (Pubitemid 36618252)
95. E.A. Stone, Y. Lin, and D. Quartermain Immobility from administration of the α1-adrenergic antagonist, terazosin, in the IVth ventricle in rats Neurosci Lett 353 2003 231 233 (Pubitemid 37510184)
96. E.A. Stone, Y. Lin, R. Ahsan, and D. Quartermain Role of locus coeruleus α1-adrenoceptors in motor activity in rats Synapse 54 2004 164 172 (Pubitemid 39435346)
97. E.A. Stone, M.L. Lehmann, Y. Lin, and D. Quartermain Depressive behavior in mice due to immune stimulation is accompanied by reduced neural activity in brain regions involved in positively motivated behavior Biol Psychiatry 60 2006 803 811 (Pubitemid 44527893)
98. E.A. Stone, M.L. Lehmann, Y. Lin, and D. Quartermain Reduced evoked fos expression in activity-related brain regions in animal models of depression Prog Neuropsychopharmacol Biol Psychiatry 31 2007 1196 1207 (Pubitemid 47081304)
99. 1- adrenoceptors by a full agonist Brain Res 1291 2009 21 31
100. E.A. Stone, Y. Lin, Y. Sarfraz, and D. Quartermain Antidepressant-like action of intracerebral 6-fluoronorepinephrine, a selective full alpha-adrenoceptor agonist Int J Neuropsychopharmacol 14 2011 319 331
101. E.A. Stone, Y. Lin, Y. Sarfraz, and D. Quartermain The role of the central noradrenergic system in behavioral inhibition Brain Res Rev 67 2011 193 208
102. Stone EA, Lin Y, Sarfraz Y. Activation of central stress systems by blockade of brainstem α1-adrenoceptors. Submitted for publication.
103. N.R. Swerdlow, G.F. Koob, M. Cador, M. Lorang, and R.L. Hauger Pituitary-adrenal axis responses to acute amphetamine in the rat Pharmacol Biochem Behav 45 1993 629 637
104. S.T. Szabo, and P. Blier Effects of chronic antidepressant drug administration and electroconvulsive shock on locus coeruleus electrophysiologic activity Biol Psychiatry 50 2001 644 (Pubitemid 33022653)
105. L.F. Takase, M.I. Nogueira, S.T. Bland, M. Baratta, L.R. Watkins, and S.F. Maier Effect of number of tailshocks on learned helplessness and activation of serotonergic and noradrenergic neurons in the rat Behav Brain Res 162 2005 299 306 (Pubitemid 40828543)
106. R.R. Traut, A. Bollen, T.T. Sun, J.W. Hershey, J. Sundberg, and L.R. Pierce Methyl 4-mercaptobutyrimidate as a cleavable cross-linking reagent and its application to the Escherichia coli 30S ribosome Biochemistry 12 1973 3266 3273
107. J.M. Weiss, P.G. Simson, L.J. Hoffman, M.J. Ambrose, S. Cooper, and A. Webster Infusion of adrenergic receptor agonists and antagonists into the locus coeruleus and ventricular system of the brain. Effects on swim-motivated and spontaneous motor activity Neuropharmacology 25 1986 367 384 (Pubitemid 16109573)
108. J.M. Weiss, K.A. Boss-Williams, J.P. Moore, M.K. Demetrikopoulos, J.C. Ritchie, and C.H.K. West Testing the hypothesis that locus coeruleus hyperactivity produces depression-related changes via galanin Neuropeptides 39 2005 281 287 (Pubitemid 40804598)
109. C.H. West, J.C. Ritchie, K.A. Boss-Williams, and J.M. Weiss Antidepressant drugs with differing pharmacological actions decrease activity of locus coeruleus neurons Int J Neuropsychopharmacol 12 2009 627 641
110. P. Willner Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation Psychopharmacology 134 1997 319 329 (Pubitemid 28023396)
111. M.L. Wong, M.A. Kling, P.J. Munson, S. Listwak, J. Licinio, and P. Prolo Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone Proc Natl Acad Sci U S A 97 2000 325 330 (Pubitemid 30055830)
112. C.C. Wrenn, M.J. Picklo, D.A. Lappi, D. Robertson, and R.G. Wiley Central noradrenergic lesioning using anti-DBH-saporin: anatomical findings Brain Res 740 1996 175 184 (Pubitemid 26411297)
113. X.-M. Yang, A.L. Gorman, and A.J. Dunn The involvement of central noradrenergic systems and corticotropin-releasing factor in defensive-withdrawal in rats J Pharmacol Exp Ther 255 1990 1064 1070
114. S.U. Yanpallewar, K. Fernandes, S.V. Marathe, K.C. Vadodaria, D. Jhaveri, and K. Rommelfanger Alpha-2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment J Neurosci 30 2010 1096 1109
115. R. Yirmiya Endotoxin produces a depressive-like episode in rats Brain Res 711 1996 163 174 (Pubitemid 26080239)
116. H.T. Zhang, L.R. Whisler, Y. Huang, Y. Xiang, and J.M. O'Donnell Postsynaptic alpha-2 adrenergic receptors are critical for the antidepressant-like effects of desipramine on behavior Neuropsychopharmacology 34 2009 1067 1077
117. M.J. Zigmond, and E.M. Stricker Supersensitivity after intraventricular 6-hydroxydopamine: relation to dopamine depletion Experientia 36 1980 436 437